Ultrafiltration of highly concentrated antibody solutions

Experiments and modeling for the effects of module and buffer conditions

Elaheh Binabaji, Junfen Ma, Suma Rao, Andrew Zydney

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Although ultrafiltration is currently used for the concentration and formulation of nearly all biotherapeutics, obtaining the very high target concentrations for monoclonal antibody products is challenging. The objective of this work was to examine the effects of the membrane module design and buffer conditions on both the filtrate flux and maximum achievable protein concentration during the ultrafiltration of highly concentrated monoclonal antibody solutions. Experimental data were obtained using both hollow fiber and screened cassettes and in the presence of specific excipients that are known to alter the solution viscosity. Data were compared with predictions of a recently developed model that accounts for the complex thermodynamic and hydrodynamic behavior in these systems, including the effects of back-filtration arising from the large pressure drop through the module due to the high viscosity of the concentrated antibody solutions. Model calculations were in good agreement with experimental data in hollow fiber modules with very different fiber length and in screened cassettes having different screen geometries. These results provide important insights into the key factors controlling the filtrate flux and maximum achievable protein concentration during ultrafiltration of highly concentrated antibody solutions as well as a framework for the development of enhanced ultrafiltration processes for this application.

Original languageEnglish (US)
Pages (from-to)692-701
Number of pages10
JournalBiotechnology Progress
Volume32
Issue number3
DOIs
StatePublished - May 1 2016

Fingerprint

Ultrafiltration
Buffers
Antibodies
Viscosity
Monoclonal Antibodies
Excipients
Hydrodynamics
Thermodynamics
Proteins
Pressure
Membranes

All Science Journal Classification (ASJC) codes

  • Biotechnology

Cite this

@article{1a430d8a02d5405885f243f7e5c53f77,
title = "Ultrafiltration of highly concentrated antibody solutions: Experiments and modeling for the effects of module and buffer conditions",
abstract = "Although ultrafiltration is currently used for the concentration and formulation of nearly all biotherapeutics, obtaining the very high target concentrations for monoclonal antibody products is challenging. The objective of this work was to examine the effects of the membrane module design and buffer conditions on both the filtrate flux and maximum achievable protein concentration during the ultrafiltration of highly concentrated monoclonal antibody solutions. Experimental data were obtained using both hollow fiber and screened cassettes and in the presence of specific excipients that are known to alter the solution viscosity. Data were compared with predictions of a recently developed model that accounts for the complex thermodynamic and hydrodynamic behavior in these systems, including the effects of back-filtration arising from the large pressure drop through the module due to the high viscosity of the concentrated antibody solutions. Model calculations were in good agreement with experimental data in hollow fiber modules with very different fiber length and in screened cassettes having different screen geometries. These results provide important insights into the key factors controlling the filtrate flux and maximum achievable protein concentration during ultrafiltration of highly concentrated antibody solutions as well as a framework for the development of enhanced ultrafiltration processes for this application.",
author = "Elaheh Binabaji and Junfen Ma and Suma Rao and Andrew Zydney",
year = "2016",
month = "5",
day = "1",
doi = "10.1002/btpr.2252",
language = "English (US)",
volume = "32",
pages = "692--701",
journal = "Biotechnology Progress",
issn = "8756-7938",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

Ultrafiltration of highly concentrated antibody solutions : Experiments and modeling for the effects of module and buffer conditions. / Binabaji, Elaheh; Ma, Junfen; Rao, Suma; Zydney, Andrew.

In: Biotechnology Progress, Vol. 32, No. 3, 01.05.2016, p. 692-701.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ultrafiltration of highly concentrated antibody solutions

T2 - Experiments and modeling for the effects of module and buffer conditions

AU - Binabaji, Elaheh

AU - Ma, Junfen

AU - Rao, Suma

AU - Zydney, Andrew

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Although ultrafiltration is currently used for the concentration and formulation of nearly all biotherapeutics, obtaining the very high target concentrations for monoclonal antibody products is challenging. The objective of this work was to examine the effects of the membrane module design and buffer conditions on both the filtrate flux and maximum achievable protein concentration during the ultrafiltration of highly concentrated monoclonal antibody solutions. Experimental data were obtained using both hollow fiber and screened cassettes and in the presence of specific excipients that are known to alter the solution viscosity. Data were compared with predictions of a recently developed model that accounts for the complex thermodynamic and hydrodynamic behavior in these systems, including the effects of back-filtration arising from the large pressure drop through the module due to the high viscosity of the concentrated antibody solutions. Model calculations were in good agreement with experimental data in hollow fiber modules with very different fiber length and in screened cassettes having different screen geometries. These results provide important insights into the key factors controlling the filtrate flux and maximum achievable protein concentration during ultrafiltration of highly concentrated antibody solutions as well as a framework for the development of enhanced ultrafiltration processes for this application.

AB - Although ultrafiltration is currently used for the concentration and formulation of nearly all biotherapeutics, obtaining the very high target concentrations for monoclonal antibody products is challenging. The objective of this work was to examine the effects of the membrane module design and buffer conditions on both the filtrate flux and maximum achievable protein concentration during the ultrafiltration of highly concentrated monoclonal antibody solutions. Experimental data were obtained using both hollow fiber and screened cassettes and in the presence of specific excipients that are known to alter the solution viscosity. Data were compared with predictions of a recently developed model that accounts for the complex thermodynamic and hydrodynamic behavior in these systems, including the effects of back-filtration arising from the large pressure drop through the module due to the high viscosity of the concentrated antibody solutions. Model calculations were in good agreement with experimental data in hollow fiber modules with very different fiber length and in screened cassettes having different screen geometries. These results provide important insights into the key factors controlling the filtrate flux and maximum achievable protein concentration during ultrafiltration of highly concentrated antibody solutions as well as a framework for the development of enhanced ultrafiltration processes for this application.

UR - http://www.scopus.com/inward/record.url?scp=85027927672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027927672&partnerID=8YFLogxK

U2 - 10.1002/btpr.2252

DO - 10.1002/btpr.2252

M3 - Article

VL - 32

SP - 692

EP - 701

JO - Biotechnology Progress

JF - Biotechnology Progress

SN - 8756-7938

IS - 3

ER -